India Gelatine & Chemicals Ltd
Incorporated in 1973, India Gelatine & Chemicals Ltd is engaged in manufacturing and export of Ossein, Di-Calcium Phosphate (DCP)& Gelatine.
- Market Cap ₹ 236 Cr.
- Current Price ₹ 332
- High / Low ₹ 450 / 307
- Stock P/E 10.3
- Book Value ₹ 256
- Dividend Yield 1.51 %
- ROCE 11.9 %
- ROE 9.22 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 20.4% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 20.9%
Cons
- The company has delivered a poor sales growth of 8.52% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 | 115 | 93 | 74 | 98 | 112 | 132 | 144 | 160 | 205 | 206 | 199 | 192 | |
| 105 | 109 | 89 | 74 | 96 | 107 | 124 | 135 | 152 | 172 | 171 | 177 | 164 | |
| Operating Profit | 15 | 6 | 4 | 1 | 2 | 5 | 7 | 9 | 8 | 33 | 35 | 21 | 28 |
| OPM % | 13% | 5% | 5% | 1% | 2% | 5% | 6% | 6% | 5% | 16% | 17% | 11% | 15% |
| 3 | 7 | 5 | 6 | 4 | 4 | 3 | 4 | 4 | 3 | 8 | 8 | 8 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 5 | 5 | 5 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 6 | 5 |
| Profit before tax | 12 | 7 | 5 | 3 | 3 | 6 | 6 | 9 | 7 | 32 | 37 | 23 | 30 |
| Tax % | 35% | 14% | 23% | -5% | 16% | -1% | 16% | 23% | 24% | 25% | 24% | 23% | |
| 8 | 6 | 4 | 3 | 2 | 6 | 5 | 7 | 6 | 24 | 28 | 17 | 23 | |
| EPS in Rs | 8.57 | 6.62 | 3.89 | 3.37 | 3.19 | 8.11 | 7.56 | 10.02 | 7.91 | 33.70 | 40.03 | 24.52 | 32.13 |
| Dividend Payout % | 21% | 23% | 23% | 27% | 63% | 43% | 20% | 25% | 32% | 15% | 27% | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 9% |
| 3 Years: | 7% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 20% |
| 3 Years: | 46% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 28% |
| 3 Years: | 23% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 11% |
| 3 Years: | 15% |
| Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 105 | 109 | 112 | 115 | 92 | 95 | 97 | 103 | 108 | 129 | 147 | 164 | 175 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 8 | 6 | 5 | |
| 34 | 35 | 35 | 17 | 17 | 14 | 19 | 17 | 22 | 33 | 22 | 17 | 24 | |
| Total Liabilities | 148 | 154 | 157 | 141 | 115 | 116 | 124 | 127 | 136 | 180 | 184 | 195 | 211 |
| 49 | 47 | 45 | 44 | 42 | 42 | 43 | 40 | 41 | 60 | 69 | 68 | 61 | |
| CWIP | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 4 | 2 | 1 | 2 |
| Investments | 13 | 13 | 7 | 36 | 30 | 30 | 28 | 34 | 33 | 43 | 44 | 55 | 68 |
| 85 | 93 | 104 | 60 | 43 | 44 | 53 | 52 | 62 | 73 | 70 | 71 | 81 | |
| Total Assets | 148 | 154 | 157 | 141 | 115 | 116 | 124 | 127 | 136 | 180 | 184 | 195 | 211 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1 | 17 | 4 | -4 | 15 | 5 | 7 | 6 | 9 | 18 | 18 | 21 | |
| 2 | 3 | 8 | -27 | -19 | -1 | -3 | -6 | -8 | -21 | -8 | -17 | |
| -3 | -2 | -2 | -1 | -1 | -2 | -3 | -1 | -2 | 7 | -13 | -4 | |
| Net Cash Flow | -2 | 18 | 10 | -32 | -5 | 2 | 1 | -1 | -1 | 3 | -3 | -0 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19 | 12 | 24 | 22 | 17 | 17 | 18 | 24 | 26 | 25 | 22 | 22 |
| Inventory Days | 208 | 198 | 187 | 365 | 209 | 180 | 178 | 129 | 130 | 176 | 182 | 136 |
| Days Payable | 29 | 19 | 22 | 54 | 48 | 23 | 52 | 25 | 36 | 60 | 41 | 19 |
| Cash Conversion Cycle | 198 | 191 | 189 | 333 | 178 | 175 | 144 | 127 | 120 | 140 | 164 | 139 |
| Working Capital Days | 149 | 111 | 139 | 206 | 112 | 102 | 90 | 95 | 95 | 66 | 81 | 78 |
| ROCE % | 11% | 3% | 2% | 1% | 2% | 6% | 7% | 7% | 6% | 24% | 22% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
5m - Outcome of Board meeting held on 29th November 2025 - Change in Management.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
11 Nov - Of newspaper publication of extract of the un-audited financial results for the quarter and half-year ended 30th September 2025.
-
Board Meeting Outcome for Outcome Of Board Meeting Held Today ,I.E Monday 10Th November 2025.
10 Nov - Unaudited Q2/H1 Sep-30-2025 results; ₹80 Cr expansion increases capacity 2,000→2,700 MT in 1.5 years.
- Un-Audited Financial Results For The Quarter & Half Year Ended 30Th September 2025. 10 Nov
-
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Reg.29 Of SEBI(LODR) Regulation, 2025
29 Oct - Board meeting on Nov 10, 2025 to approve Q2/H1 Sep 30, 2025 unaudited results; trading window closed Oct 1–Nov 12, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Portfolio:[1]
a) Edible Gelatine: Being odorless & tasteless, Company's Gelatine can be mixed in any foodstuff.
b) Photographic Gelatine: This kind of gelatine has an ability to form a solution when heated and then come back to jelly form when cooled and to remain durable after water has been removed making it very useful for photographic industry.
c) Technical Gelatine: It is a good clarifying agent used in metal electrolysis. Gelatine strengthens nails and promotes hair growth therefore it is used in cosmetic industry. Also, match box industry utilizes its thickening & foaming properties to make match heads.
d) Pharmaceutical Gelatine: It is ideal for manufacture of hard & soft shell gelatine capsules. It is also used to treat wounds & as life saving blood plasma substitute.